4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001193125-25-320941
Chief Discovery Officer sold 8,000 shares at $22.64 ($181,159)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Discovery Officer | 2025-12-12 | Sale 10b5-1 | −8,000 | $22.64 | $181,159 | 162,981 | D: show line 1 in the form |
| Open-market sales · 8,000 sh · avg $22.64 · $181,159 | |||||||
Loading xslF345X05/ownership.xml…